Multivariable adaptive closed-loop control of an artificial pancreas without meal and activity announcement.

BACKGROUND Accurate closed-loop control is essential for developing artificial pancreas (AP) systems that adjust insulin infusion rates from insulin pumps. Glucose concentration information from continuous glucose monitoring (CGM) systems is the most important information for the control system. Additional physiological measurements can provide valuable information that can enhance the accuracy of the control system. Proportional-integral-derivative control and model predictive control have been popular in AP development. Their implementations to date rely on meal announcements (e.g., bolus insulin dose based on insulin:carbohydrate ratios) by the user. Adaptive control techniques provide a powerful alternative that do not necessitate any meal or activity announcements. MATERIALS AND METHODS Adaptive control systems based on the generalized predictive control framework are developed by extending the recursive modeling techniques. Physiological signals such as energy expenditure and galvanic skin response are used along with glucose measurements to generate a multiple-input-single-output model for predicting future glucose concentrations used by the controller. Insulin-on-board (IOB) is also estimated and used in control decisions. The controllers were tested with clinical studies that include seven cases with three different patients with type 1 diabetes for 32 or 60 h without any meal or activity announcements. RESULTS The adaptive control system kept glucose concentration in the normal preprandial and postprandial range (70-180 mg/dL) without any meal or activity announcements during the test period. After IOB estimation was added to the control system, mild hypoglycemic episodes were observed only in one of the four experiments. This was reflected in a plasma glucose value of 56 mg/dL (YSI 2300 STAT; Yellow Springs Instrument, Yellow Springs, OH) and a CGM value of 63 mg/dL). CONCLUSIONS Regulation of blood glucose concentration with an AP using adaptive control techniques was successful in clinical studies, even without any meal and physical activity announcement.

[1]  David W. Clarke,et al.  Generalized predictive control - Part I. The basic algorithm , 1987, Autom..

[2]  David W. Clarke,et al.  Generalized Predictive Control - Part II Extensions and interpretations , 1987, Autom..

[3]  Cedric X. Bryant,et al.  ACSM's guidelines for exercise testing and prescription , 1995 .

[4]  F. G. Shinskey,et al.  Process Control: As Taught vs as Practiced , 2002 .

[5]  Guy Plasqui,et al.  Physical activity and human energy expenditure , 2004, Current opinion in clinical nutrition and metabolic care.

[6]  B. Bequette.  A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas. , 2005, Diabetes technology & therapeutics.

[7]  G. Steil,et al.  Feasibility of Automating Insulin Delivery for the Treatment of Type 1 Diabetes , 2006, Diabetes.

[8]  Bruce S. Sterling,et al.  Galvanic Skin Response as a Measure of Soldier Stress , 2007 .

[9]  E. Camacho,et al.  Generalized Predictive Control , 2007 .

[10]  Eyal Dassau,et al.  Safety Constraints in an Artificial Pancreatic β Cell: An Implementation of Model Predictive Control with Insulin on Board , 2009, Journal of diabetes science and technology.

[11]  S. Patek,et al.  Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: The Virginia Experience , 2009, Journal of diabetes science and technology.

[12]  L. Magni,et al.  Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: Preliminary Studies in Padova and Montpellier , 2009, Journal of diabetes science and technology.

[13]  C. Cobelli,et al.  In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes , 2009, Journal of diabetes science and technology.

[14]  Ali Cinar,et al.  Adaptive control strategy for regulation of blood glucose levels in patients with type 1 diabetes , 2009 .

[15]  C. C. Palerm,et al.  Closed-Loop Insulin Delivery Using a Subcutaneous Glucose Sensor and Intraperitoneal Insulin Delivery , 2009, Diabetes Care.

[16]  Hyunjin Lee,et al.  A closed-loop artificial pancreas based on model predictive control: Human-friendly identification and automatic meal disturbance rejection , 2009, Biomed. Signal Process. Control..

[17]  Janet M. Allen,et al.  Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial , 2010, The Lancet.

[18]  Gregory J Welk,et al.  Accuracy of armband monitors for measuring daily energy expenditure in healthy adults. , 2010, Medicine and science in sports and exercise.

[19]  Robert G. Sutherlin,et al.  A Bihormonal Closed-Loop Artificial Pancreas for Type 1 Diabetes , 2010, Science Translational Medicine.

[20]  L. Magni,et al.  Multinational Study of Subcutaneous Model-Predictive Closed-Loop Control in Type 1 Diabetes Mellitus: Summary of the Results , 2010, Journal of diabetes science and technology.

[21]  C. Cobelli,et al.  Artificial Pancreas: Past, Present, Future , 2011, Diabetes.

[22]  W. Kenneth Ward,et al.  Safe Glycemic Management during Closed-Loop Treatment of Type 1 Diabetes: The Role of Glucagon, Use of Multiple Sensors, and Compensation for Stress Hyperglycemia , 2011, Journal of diabetes science and technology.

[23]  Cesar C. Palerm,et al.  Physiologic insulin delivery with insulin feedback: A control systems perspective , 2011, Comput. Methods Programs Biomed..

[24]  Anirban Roy,et al.  The effect of insulin feedback on closed loop glucose control. , 2011, The Journal of clinical endocrinology and metabolism.

[25]  D. Dunger,et al.  Closed-loop insulin delivery for treatment of type 1 diabetes , 2011, BMC medicine.

[26]  Anirban Roy,et al.  Effect of Pramlintide on Prandial Glycemic Excursions During Closed-Loop Control in Adolescents and Young Adults With Type 1 Diabetes , 2012, Diabetes Care.

[27]  Ali Cinar,et al.  Adaptive system identification for estimating future glucose concentrations and hypoglycemia alarms , 2012, Autom..

[28]  Howard C. Zisser,et al.  Fully Integrated Artificial Pancreas in Type 1 Diabetes , 2012, Diabetes.

[29]  Stuart A Weinzimer,et al.  Effect of Insulin Feedback on Closed-Loop Glucose Control: A Crossover Study , 2012, Journal of diabetes science and technology.

[30]  F. El-Khatib,et al.  Blood Glucose Control in Type 1 Diabetes With a Bihormonal Bionic Endocrine Pancreas , 2012, Diabetes Care.

[31]  Roman Hovorka,et al.  Closed-loop insulin delivery in type 1 diabetes. , 2012, Endocrinology and metabolism clinics of North America.

[32]  B. Wayne Bequette,et al.  Challenges and recent progress in the development of a closed-loop artificial pancreas , 2012, Annu. Rev. Control..

[33]  Howard C. Zisser,et al.  Clinical Evaluation of a Personalized Artificial Pancreas , 2013, Diabetes Care.

[34]  Ali Cinar,et al.  Adaptive multivariable closed-loop control of blood glucose concentration in patients with Type 1 Diabetes , 2013, 2013 American Control Conference.